Report Overview

The Australian Renal Cancer market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Kidney cancer was the 7th most diagnosed cancer in Australia in 2016. It is estimated that it will remain the 7th most diagnosed cancer in 2020. More than 3000 people are diagnosed with kidney cancer in Australia each year. It makes up about 2.5% of all cancers. It is twice as common in men as women and is the ninth most diagnosed cancer for Australian men. The risk of kidney cancer increases with age, and most cases occur in people over 50. Renal cell cancer (also called kidney cancer or renal cell adenocarcinoma) is a disease in which malignant (cancer) cells are found in the lining of tubules (very small tubes) in the kidney. There are 2 kidneys, one on each side of the backbone, above the waist. Tiny tubules in the kidneys filter and clean the blood. They take out waste products and make urine. The urine passes from each kidney through a long tube called a ureter into the bladder. The bladder holds the urine until it passes through the urethra and leaves the body.



Market Drivers

The mortality rate for kidney cancer is expected to increase with age which shows a positive impact on the market. Thus, the increasing prevalence of kidney cancer, the growing geriatric population along with that awareness about cancer is the major factors driving the segment and expected to do over the forecast period. Few other drivers of the renal cell carcinoma market include changing lifestyles, misuse of certain painkillers, & obesity.

The population above 60 years of age forms the target demographic segment for this vertical, as this population subset is more prone to neurological conditions. The advancement of diagnostics equipment increases the lifespan of this demographic and improves the quality of life for those suffering from neurological conditions. Hence, the presence of a large geriatric population pool is considered a vital driver for this industry.

Epidemiology

In 2016, there were 3,627 new cases of kidney cancer diagnosed in Australia (2,408 males and 1,219 females). In 2020, it is estimated that 4,193 new cases of kidney cancer will be diagnosed in Australia (2,755 males and 1,438 females).

In 2018, there were 875 deaths from kidney cancer in Australia (579 males and 296 females). In 2020, it is estimated that there will be 917 deaths (616 males and 301 females).

In 20122016, individuals diagnosed with kidney cancer had a 79 % chance (78% for males and 79% for females) of surviving for five years compared to their counterparts in the general Australian population.

At the end of 2015, there were 3,229 people living who had been diagnosed with kidney cancer that year, 13,127 people living who had been diagnosed with kidney cancer in the previous 5 years.